<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">medsovet</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинский Совет</journal-title><trans-title-group xml:lang="en"><trans-title>Meditsinskiy sovet = Medical Council</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2079-701X</issn><issn pub-type="epub">2658-5790</issn><publisher><publisher-name>REMEDIUM GROUP Ltd.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21518/ms2025-478</article-id><article-id custom-type="elpub" pub-id-type="custom">medsovet-9518</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ПРЕГРАВИДАРНАЯ ПОДГОТОВКА И БЕРЕМЕННОСТЬ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>PREGRAVID PREPARATION AND PREGNANCY</subject></subj-group></article-categories><title-group><article-title>Особенности течения беременности и родов у пациентки с гиперпаратиреозом</article-title><trans-title-group xml:lang="en"><trans-title>Characteristics of pregnancy and delivery in patients with hyperparathyroidism</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5230-9961</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Батрак</surname><given-names>Н. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Batrak</surname><given-names>N. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Батрак Наталья Владимировна - к.м.н., доцент кафедры акушерства, гинекологии и медицинской генетики.</p><p>153012, Иваново, Шереметевский проспект, д. 8</p></bio><bio xml:lang="en"><p>Nataliya V. Batrak - Cand. Sci. (Med.), Associate Professor of the Department Obstetrics, Gynecology and Medical Genetics.</p><p>8, Sheremetevsky Ave., Ivanovo, 153012</p></bio><email xlink:type="simple">batrakn@inbox.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7874-2176</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Батрак</surname><given-names>Г. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Batrak</surname><given-names>G. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Батрак Галина Алексеевна - д.м.н., профессор кафедры терапии, эндокринологии и диетологии.</p><p>153012, Иваново, Шереметевский проспект, д. 8</p></bio><bio xml:lang="en"><p>Galina A. Batrak - Dr. Sci. (Med.), Professor of the Department of Therapy, Endocrinology and Dietology.</p><p>8, Sheremetevsky Ave., Ivanovo, 153012</p></bio><email xlink:type="simple">gbatrak@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0007-4176-548X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Стрижова</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Strizhova</surname><given-names>A. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Стрижова Александра Валерьевна – студент.</p><p>153012, Иваново, Шереметевский проспект, д. 8</p></bio><bio xml:lang="en"><p>Aleksandra V. Strizhova – Student.</p><p>8, Sheremetevsky Ave., Ivanovo, 153012</p></bio><email xlink:type="simple">alya.strizhova.01@bk.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0008-7441-8510</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Слепнева</surname><given-names>Я. Д.</given-names></name><name name-style="western" xml:lang="en"><surname>Slepneva</surname><given-names>Yа. D.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Слепнева Яна Дмитриевна – студент.</p><p>153012, Иваново, Шереметевский проспект, д. 8</p></bio><bio xml:lang="en"><p>Yana D. Slepneva – Student.</p><p>8, Sheremetevsky Ave., Ivanovo, 153012</p></bio><email xlink:type="simple">yana.slepneva.02@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4028-0708</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Жабурина</surname><given-names>М. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Zhaburina</surname><given-names>M. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Жабурина Мария Владимировна - к.м.н., доцент кафедры оториноларингологии и офтальмологии.</p><p>153012, Иваново, Шереметевский проспект, д. 8</p></bio><bio xml:lang="en"><p>Maria V. Zhaburina - Cand. Sci. (Med.), Associate Professor of the Department of Otorhinolaryngology and Ophthalmology.</p><p>8, Sheremetevsky Ave., Ivanovo, 153012</p></bio><email xlink:type="simple">mari9065122928@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Ивановский государственный медицинский университет</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Ivanovo State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>20</day><month>11</month><year>2025</year></pub-date><volume>0</volume><issue>17</issue><fpage>81</fpage><lpage>86</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Батрак Н.В., Батрак Г.А., Стрижова А.В., Слепнева Я.Д., Жабурина М.В., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Батрак Н.В., Батрак Г.А., Стрижова А.В., Слепнева Я.Д., Жабурина М.В.</copyright-holder><copyright-holder xml:lang="en">Batrak N.V., Batrak G.A., Strizhova A.A., Slepneva Y.D., Zhaburina M.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.med-sovet.pro/jour/article/view/9518">https://www.med-sovet.pro/jour/article/view/9518</self-uri><abstract><p>Первичный гиперпаратиреоз (ПГПТ) – редкое эндокринное заболевание, которое является наиболее распространенной причиной гиперкальциемии у небеременных женщин. В научной литературе и клинической практике акушера-гинеколога и эндокринолога планирование, наступление беременности и рождение здорового ребенка у женщины с ПГПТ представлены в редких случаях и, несомненно, вызывают научно-практический интерес. Из практики гинеколога и эндокринолога представлен клинический случай пациентки, у которой на фоне гиперпаратиреоза наступила беременность. Описаны анамнез и клиническая картина заболевания, данные гормональных и инструментальных методов обследования, проводимое лечение. Пациентка с гиперпаратиреозом и беременностью наблюдалась эндокринологом и гинекологом весь период гестации, проводились в динамике необходимые лабораторные и инструментальные методы обследования, постоянный контроль клинического состояния, коррекция лекарственной терапии. В настоящее время не существует единого мнения о лечении ПГПТ во время беременности; для беременных женщин с ПГПТ требуется индивидуальный подход к терапии. Тактика ведения беременности у женщин с ПГПТ зависит от тяжести симптомов, гестационного возраста на момент проявления, возраста, сопутствующих заболеваний и осложнений. У женщин детородного возраста с ПГПТ, выявленным до беременности, крайне важно организовать прегравидарное консультирование и провести радикальную операцию на основе основной этиологии ПГПТ до зачатия. Для достижения оптимальных результатов для матери и плода рекомендуется междисциплинарный подход с тесным взаимодействием эндокринолога, акушера и педиатра. Особые случаи (рак паращитовидных желез, синдромные формы) должны сопровождаться индивидуальным планом лечения в специализированном эндокринном отделении. Ведение ПГПТ во время беременности должно основываться на гестационном возрасте, тяжести гиперкальциемии и балансе риска и пользы для матери и плода.</p></abstract><trans-abstract xml:lang="en"><p>Primary hyperparathyroidism (PHPT) is a rare endocrine disease, but it is the most common cause of hypercalcemia in non-pregnant women. In the scientific literature and clinical practice of an obstetrician-gynecologist and endocrinologist, planning, pregnancy and the birth of a healthy child in a woman with PHPT are presented in rare cases and undoubtedly arouse scientific and practical interest. A clinical case from the practice of a gynecologist and endocrinologist of a patient who became pregnant against the background of hyperparathyroidism is presented. The history and clinical picture of the disease, the data of hormonal and instrumental methods of examination, and the treatment are described. A patient with hyperparathyroidism and pregnancy was observed by an endocrinologist and a gynecologist throughout the entire gestational period, the necessary laboratory and instrumental methods of examination, constant monitoring of the clinical condition, and correction of drug therapy were carried out in dynamics. Currently, there is no consensus on the treatment of PHPT during pregnancy, and an individualized approach to therapy is required for pregnant women with PHPT. The management of pregnancy in women with PHPT depends on the severity of symptoms, gestational age at the time of manifestation, age, concomitant diseases and complications. In women of childbearing potential with PHPT detected before pregnancy, it is essential to provide preconception counseling and radical surgery based on the underlying etiology of PHPT before conception. For optimal maternal and fetal outcomes, a multidisciplinary approach is recommended with close collaboration between an endocrinologist, obstetrician, and pediatrician. Special cases (parathyroid cancer, syndromic forms) should be accompanied by an individual treatment plan in a specialized endocrine department. The management of PHPT during pregnancy should be based on gestational age, severity of hypercalcemia, and the balance of risk and benefit to the mother and fetus.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>первичный гиперпаратиреоз</kwd><kwd>беременность</kwd><kwd>гиперкальциемия</kwd><kwd>паратиреоидный гормон</kwd><kwd>щитовидная железа</kwd><kwd>паращитовидные железы</kwd></kwd-group><kwd-group xml:lang="en"><kwd>primary hyperparathyroidism</kwd><kwd>pregnancy</kwd><kwd>hypercalcemia</kwd><kwd>parathyroid hormone</kwd><kwd>thyroid gland</kwd><kwd>parathyroid glands</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Khan AA, Hanley DA, Rizzoli R, Bollerslev J, Young J, Rejnmark L et al. Primary hyperparathyroidism: Review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus. Osteoporos Int. 2017;28:1–19. https://doi.org/10.1007/s00198-016-3716-2.</mixed-citation><mixed-citation xml:lang="en">Khan AA, Hanley DA, Rizzoli R, Bollerslev J, Young J, Rejnmark L et al. Primary hyperparathyroidism: Review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus. Osteoporos Int. 2017;28:1–19. https://doi.org/10.1007/s00198-016-3716-2.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Nadarasa K, Bailey M, Chahal H, Raja O, Bhat R, Gayle C et al. The use of cinacalcet in pregnancy to treat a complex case of parathyroid carcinoma. Endocrinol Diabetes Metab Case Rep. 2014;2014:140056. https://doi.org/10.1530/EDM-14-0056.</mixed-citation><mixed-citation xml:lang="en">Nadarasa K, Bailey M, Chahal H, Raja O, Bhat R, Gayle C et al. The use of cinacalcet in pregnancy to treat a complex case of parathyroid carcinoma. Endocrinol Diabetes Metab Case Rep. 2014;2014:140056. https://doi.org/10.1530/EDM-14-0056.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Marini F, Cianferotti L, Giusti F, Brandi ML. Molecular genetics in primary hyperparathyroidism: the role of genetic tests in differential diagnosis, disease prevention strategy, and therapeutic planning. A 2017 update. Clin Cases Miner Bone Metab. 2017;14(1):60–70. https://doi.org/10.11138/ccmbm/2017.14.1.060.</mixed-citation><mixed-citation xml:lang="en">Marini F, Cianferotti L, Giusti F, Brandi ML. Molecular genetics in primary hyperparathyroidism: the role of genetic tests in differential diagnosis, disease prevention strategy, and therapeutic planning. A 2017 update. Clin Cases Miner Bone Metab. 2017;14(1):60–70. https://doi.org/10.11138/ccmbm/2017.14.1.060.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Davis C, Nippita T. Hyperparathyroidism in pregnancy. BMJ Case Rep. 2020;13(2):e232653. https://doi.org/10.1136/bcr-2019-232653.</mixed-citation><mixed-citation xml:lang="en">Davis C, Nippita T. Hyperparathyroidism in pregnancy. BMJ Case Rep. 2020;13(2):e232653. https://doi.org/10.1136/bcr-2019-232653.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Dale AG, Holbrook BD, Sobel L, Rappaport VJ. Hyperparathyroidism in Pregnancy Leading to Pancreatitis and Preeclampsia with Severe Features. Case Rep Obstet Gynecol. 2017;2017:6061313. https://doi.org/10.1155/2017/6061313.</mixed-citation><mixed-citation xml:lang="en">Dale AG, Holbrook BD, Sobel L, Rappaport VJ. Hyperparathyroidism in Pregnancy Leading to Pancreatitis and Preeclampsia with Severe Features. Case Rep Obstet Gynecol. 2017;2017:6061313. https://doi.org/10.1155/2017/6061313.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Rigg J, Gilbertson E, Barrett HL, Britten FL, Lust K. Primary Hyperparathyroidism in Pregnancy: Maternofetal Outcomes at a Quaternary Referral Obstetric Hospital, 2000 Through 2015. J Clin Endocrinol Metab. 2019;104(3):721–729. https://doi.org/10.1210/jc.2018-01104.</mixed-citation><mixed-citation xml:lang="en">Rigg J, Gilbertson E, Barrett HL, Britten FL, Lust K. Primary Hyperparathyroidism in Pregnancy: Maternofetal Outcomes at a Quaternary Referral Obstetric Hospital, 2000 Through 2015. J Clin Endocrinol Metab. 2019;104(3):721–729. https://doi.org/10.1210/jc.2018-01104.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Ali DS, Dandurand K, Khan AA. Primary Hyperparathyroidism in Pregnancy: Literature Review of the Diagnosis and Management. J Clin Med. 2021;10(13):2956. https://doi.org/10.3390/jcm10132956.</mixed-citation><mixed-citation xml:lang="en">Ali DS, Dandurand K, Khan AA. Primary Hyperparathyroidism in Pregnancy: Literature Review of the Diagnosis and Management. J Clin Med. 2021;10(13):2956. https://doi.org/10.3390/jcm10132956.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">DiMarco AN, Meeran K, Christakis I, Sodhi V, Nelson-Piercy C, Tolley NS, Palazzo FF. Seventeen Cases of Primary Hyperparathyroidism in Pregnancy: A Call for Management Guidelines. J Endocr Soc. 2019;3(5):1009–1021. https://doi.org/10.1210/js.2018-00340.</mixed-citation><mixed-citation xml:lang="en">DiMarco AN, Meeran K, Christakis I, Sodhi V, Nelson-Piercy C, Tolley NS, Palazzo FF. Seventeen Cases of Primary Hyperparathyroidism in Pregnancy: A Call for Management Guidelines. J Endocr Soc. 2019;3(5):1009–1021. https://doi.org/10.1210/js.2018-00340.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Rey E, Jacob CE, Koolian M, Morin F. Hypercalcemia in pregnancy – a multifaceted challenge: case reports and literature review. Clin Case Rep. 2016;4(10):1001–1008. https://doi.org/10.1002/ccr3.646.</mixed-citation><mixed-citation xml:lang="en">Rey E, Jacob CE, Koolian M, Morin F. Hypercalcemia in pregnancy – a multifaceted challenge: case reports and literature review. Clin Case Rep. 2016;4(10):1001–1008. https://doi.org/10.1002/ccr3.646.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Mokrysheva NG, Eremkina AK, Mirnaya S, Rozhinskaya LY, Kuznetsov NS, Yesayan RM et al. A Case of Pregnancy Complicated by Primary Hyperparathyroidism Due to a Parathyroid Adenoma. Am J Case Rep. 2019;20:53–59. https://doi.org/10.12659/AJCR.912436.</mixed-citation><mixed-citation xml:lang="en">Mokrysheva NG, Eremkina AK, Mirnaya S, Rozhinskaya LY, Kuznetsov NS, Yesayan RM et al. A Case of Pregnancy Complicated by Primary Hyperparathyroidism Due to a Parathyroid Adenoma. Am J Case Rep. 2019;20:53–59. https://doi.org/10.12659/AJCR.912436.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Refardt J, Farina P, Hoesli I, Meier C. Hypercalcemic crisis in third trimenon: evaluating the optimal treatment strategy. Gynecol Endocrinol. 2018;34(10):833–836. https://doi.org/10.1080/09513590.2018.1462314.</mixed-citation><mixed-citation xml:lang="en">Refardt J, Farina P, Hoesli I, Meier C. Hypercalcemic crisis in third trimenon: evaluating the optimal treatment strategy. Gynecol Endocrinol. 2018;34(10):833–836. https://doi.org/10.1080/09513590.2018.1462314.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Cassir G, Sermer C, Malinowski AK. Impact of Perinatal Primary Hyperparathyroidism on Maternal and Fetal and Neonatal Outcomes: Retrospective Case Series. J Obstet Gynaecol Can. 2020;42(6):750–756. https://doi.org/10.1016/j.jogc.2019.12.017.</mixed-citation><mixed-citation xml:lang="en">Cassir G, Sermer C, Malinowski AK. Impact of Perinatal Primary Hyperparathyroidism on Maternal and Fetal and Neonatal Outcomes: Retrospective Case Series. J Obstet Gynaecol Can. 2020;42(6):750–756. https://doi.org/10.1016/j.jogc.2019.12.017.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Jones AR, Hare MJ, Brown J, Yang J, Meyer C, Milat F, Allan CA. Familial Hypocalciuric Hypercalcemia in Pregnancy: Diagnostic Pitfalls. JBMR Plus. 2020;4(6):e10362. https://doi.org/10.1002/jbm4.10362.</mixed-citation><mixed-citation xml:lang="en">Jones AR, Hare MJ, Brown J, Yang J, Meyer C, Milat F, Allan CA. Familial Hypocalciuric Hypercalcemia in Pregnancy: Diagnostic Pitfalls. JBMR Plus. 2020;4(6):e10362. https://doi.org/10.1002/jbm4.10362.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Tay D, Das JP, Yeh R. Preoperative Localization for Primary Hyperparathyroidism: A Clinical Review. Biomedicines. 2021;9(4):390. https://doi.org/10.3390/biomedicines9040390.</mixed-citation><mixed-citation xml:lang="en">Tay D, Das JP, Yeh R. Preoperative Localization for Primary Hyperparathyroidism: A Clinical Review. Biomedicines. 2021;9(4):390. https://doi.org/10.3390/biomedicines9040390.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Bollerslev J, Rejnmark L, Zahn A, Heck A, Appelman-Dijkstra NM, Cardoso L et al. European Expert Consensus on Practical Management of Specific Aspects of Parathyroid Disorders in Adults and in Pregnancy: Recommendations of the ESE Educational Program of Parathyroid Disorders. Eur J Endocrinol. 2022;186(2):R33–R63. https://doi.org/10.1530/EJE-21-1044.</mixed-citation><mixed-citation xml:lang="en">Bollerslev J, Rejnmark L, Zahn A, Heck A, Appelman-Dijkstra NM, Cardoso L et al. European Expert Consensus on Practical Management of Specific Aspects of Parathyroid Disorders in Adults and in Pregnancy: Recommendations of the ESE Educational Program of Parathyroid Disorders. Eur J Endocrinol. 2022;186(2):R33–R63. https://doi.org/10.1530/EJE-21-1044.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Appelman-Dijkstra NM, Ertl DA, Zillikens MC, Rjenmark L, Winter EM. Hypercalcemia during pregnancy: management and outcomes for mother and child. Endocrine. 2021;71(3):604–610. https://doi.org/10.1007/s12020-021-02615-2.</mixed-citation><mixed-citation xml:lang="en">Appelman-Dijkstra NM, Ertl DA, Zillikens MC, Rjenmark L, Winter EM. Hypercalcemia during pregnancy: management and outcomes for mother and child. Endocrine. 2021;71(3):604–610. https://doi.org/10.1007/s12020-021-02615-2.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Sandler ML, Ho R, Xing MH, Gidumal S, Spitzer H, Levy JC, Chai RL. Primary Hyperparathyroidism During Pregnancy Treated With Parathyroidectomy: A Systematic Review. Laryngoscope. 2021;131(8):1915–1921. https://doi.org/10.1002/lary.29489.</mixed-citation><mixed-citation xml:lang="en">Sandler ML, Ho R, Xing MH, Gidumal S, Spitzer H, Levy JC, Chai RL. Primary Hyperparathyroidism During Pregnancy Treated With Parathyroidectomy: A Systematic Review. Laryngoscope. 2021;131(8):1915–1921. https://doi.org/10.1002/lary.29489.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Pereyra PLM, Aciar MLÁ, Fregenal MM, Ceballos GA, Ramírez Stieben LA. Primary hyperparathyroidism in pregnancy: a case report highlighting uncommon complication. Hiperparatiroidismo primario en el embarazo: reporte de caso destacando una complicación infrecuente. Medicina. 2024;84(2):342–346. Available at: https://pubmed.ncbi.nlm.nih.gov/38683521.</mixed-citation><mixed-citation xml:lang="en">Pereyra PLM, Aciar MLÁ, Fregenal MM, Ceballos GA, Ramírez Stieben LA. Primary hyperparathyroidism in pregnancy: a case report highlighting uncommon complication. Hiperparatiroidismo primario en el embarazo: reporte de caso destacando una complicación infrecuente. Medicina. 2024;84(2):342–346. Available at: https://pubmed.ncbi.nlm.nih.gov/38683521.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Bilezikian JP, Khan AA, Silverberg ShJ, Fuleihan GhEH, Marcocci C, Minisola S et al. Evaluation and Management of Primary Hyperparathyroidism: Summary Statement and Guidelines from the Fifth International Workshop. J Bone Miner Res. 2022;37(11):2293–2314. https://doi.org/10.1002/jbmr.4677.</mixed-citation><mixed-citation xml:lang="en">Bilezikian JP, Khan AA, Silverberg ShJ, Fuleihan GhEH, Marcocci C, Minisola S et al. Evaluation and Management of Primary Hyperparathyroidism: Summary Statement and Guidelines from the Fifth International Workshop. J Bone Miner Res. 2022;37(11):2293–2314. https://doi.org/10.1002/jbmr.4677.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Bollerslev J, Schalin-Jantti C, Rejnmark L, Siggelkow H, Morreau H, Thakker R et al. Management of endocrine disease: Unmet therapeutic, educational and scientific needs in parathyroid disorders. Eur J Endocrinol. 2019;181(3):P1–P19. https://doi.org/10.1530/EJE-19-0316.</mixed-citation><mixed-citation xml:lang="en">Bollerslev J, Schalin-Jantti C, Rejnmark L, Siggelkow H, Morreau H, Thakker R et al. Management of endocrine disease: Unmet therapeutic, educational and scientific needs in parathyroid disorders. Eur J Endocrinol. 2019;181(3):P1–P19. https://doi.org/10.1530/EJE-19-0316.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Bollerslev J, Rejnmark L, Marcocci C, Shoback DM, Sitges-Serra A, van Biesen W, Dekkers OM. European Society of Endocrinology Clinical Guideline: Treatment of chronic hypoparathyroidism in adults. Eur J Endocrinol. 2015;173(2):G1–G20. https://doi.org/10.1530/EJE-15-0628.</mixed-citation><mixed-citation xml:lang="en">Bollerslev J, Rejnmark L, Marcocci C, Shoback DM, Sitges-Serra A, van Biesen W, Dekkers OM. European Society of Endocrinology Clinical Guideline: Treatment of chronic hypoparathyroidism in adults. Eur J Endocrinol. 2015;173(2):G1–G20. https://doi.org/10.1530/EJE-15-0628.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Zavatta G, Tebben PJ, McCollough CH, Yu L, Vrieze T, Clarke BL. Basal Ganglia Calcification Is Associated With Local and Systemic Metabolic Mechanisms in Adult Hypoparathyroidism. J Clin Endocrinol Metab. 2021;106(7):1900–1917. https://doi.org/10.1210/clinem/dgab162.</mixed-citation><mixed-citation xml:lang="en">Zavatta G, Tebben PJ, McCollough CH, Yu L, Vrieze T, Clarke BL. Basal Ganglia Calcification Is Associated With Local and Systemic Metabolic Mechanisms in Adult Hypoparathyroidism. J Clin Endocrinol Metab. 2021;106(7):1900–1917. https://doi.org/10.1210/clinem/dgab162.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Khan AA, Koch CA, Van Uum S, Baillargeon JP, Bollerslev J, Brandi ML et al. Standards of care for hypoparathyroidism in adults: a Canadian and International Consensus. Eur J Endocrinol. 2019;180(3):P1–P22. https://doi.org/10.1530/EJE-18-0609.</mixed-citation><mixed-citation xml:lang="en">Khan AA, Koch CA, Van Uum S, Baillargeon JP, Bollerslev J, Brandi ML et al. Standards of care for hypoparathyroidism in adults: a Canadian and International Consensus. Eur J Endocrinol. 2019;180(3):P1–P22. https://doi.org/10.1530/EJE-18-0609.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Kamenický P, Lecoq AL, Chanson P. Primary hyperparathyroidism in pregnancy. Ann Endocrinol. 2016;77(2):169–171. https://doi.org/10.1016/j.ando.2016.04.010.</mixed-citation><mixed-citation xml:lang="en">Kamenický P, Lecoq AL, Chanson P. Primary hyperparathyroidism in pregnancy. Ann Endocrinol. 2016;77(2):169–171. https://doi.org/10.1016/j.ando.2016.04.010.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Mantovani G, Bastepe M, Monk D, de Sanctis L, Thiele S, Usardi A et al. Diagnosis and management of pseudohypoparathyroidism and related disorders: first international Consensus Statement. Nat Rev Endocrinol. 2018;14(8):476–500. https://doi.org/10.1038/s41574-018-0042-0.</mixed-citation><mixed-citation xml:lang="en">Mantovani G, Bastepe M, Monk D, de Sanctis L, Thiele S, Usardi A et al. Diagnosis and management of pseudohypoparathyroidism and related disorders: first international Consensus Statement. Nat Rev Endocrinol. 2018;14(8):476–500. https://doi.org/10.1038/s41574-018-0042-0.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Kovacs CS. Maternal Mineral and Bone Metabolism During Pregnancy, Lactation, and Post-Weaning Recovery. Physiol Rev. 2016;96(2):449–547. https://doi.org/10.1152/physrev.00027.2015.</mixed-citation><mixed-citation xml:lang="en">Kovacs CS. Maternal Mineral and Bone Metabolism During Pregnancy, Lactation, and Post-Weaning Recovery. Physiol Rev. 2016;96(2):449–547. https://doi.org/10.1152/physrev.00027.2015.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Hassan-Smith ZK, Criseno S, Gittoes NJL. Mild primary hyperparathyroidismto treat or not to treat? Br Med Bull. 2019;129(1):53–67. https://doi.org/10.1093/bmb/ldy042.</mixed-citation><mixed-citation xml:lang="en">Hassan-Smith ZK, Criseno S, Gittoes NJL. Mild primary hyperparathyroidismto treat or not to treat? Br Med Bull. 2019;129(1):53–67. https://doi.org/10.1093/bmb/ldy042.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Bollerslev J, Marcocci C, Sosa M, Nordenström J, Bouillon R, Mosekilde L. Current evidence for recommendation of surgery, medical treatment and vitamin D repletion in mild primary hyperparathyroidism. Eur J Endocrinol. 2011;165(6):851–864. https://doi.org/10.1530/EJE-11-0589.</mixed-citation><mixed-citation xml:lang="en">Bollerslev J, Marcocci C, Sosa M, Nordenström J, Bouillon R, Mosekilde L. Current evidence for recommendation of surgery, medical treatment and vitamin D repletion in mild primary hyperparathyroidism. Eur J Endocrinol. 2011;165(6):851–864. https://doi.org/10.1530/EJE-11-0589.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Dershem R, Gorvin CM, Metpally RPR, Krishnamurthy S, Smelser DT, Hannan FM et al. Familial Hypocalciuric Hypercalcemia Type 1 and Autosomal-Dominant Hypocalcemia Type 1: Prevalence in a Large Healthcare Population. Am J Hum Genet. 2020;106(6):734–747. https://doi.org/10.1016/j.ajhg.2020.04.006.</mixed-citation><mixed-citation xml:lang="en">Dershem R, Gorvin CM, Metpally RPR, Krishnamurthy S, Smelser DT, Hannan FM et al. Familial Hypocalciuric Hypercalcemia Type 1 and Autosomal-Dominant Hypocalcemia Type 1: Prevalence in a Large Healthcare Population. Am J Hum Genet. 2020;106(6):734–747. https://doi.org/10.1016/j.ajhg.2020.04.006.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Mouly C, Vargas-Poussou R, Lienhardt A, Silve C, Hureaux M, Magdelaine C et al. Clinical characteristics of familial hypocalciuric hypercalcaemia type 1: A multicentre study of 77 adult patients. Clin Endocrinol. 2020;93(3):248–260. https://doi.org/10.1111/cen.14211.</mixed-citation><mixed-citation xml:lang="en">Mouly C, Vargas-Poussou R, Lienhardt A, Silve C, Hureaux M, Magdelaine C et al. Clinical characteristics of familial hypocalciuric hypercalcaemia type 1: A multicentre study of 77 adult patients. Clin Endocrinol. 2020;93(3):248–260. https://doi.org/10.1111/cen.14211.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
